NCT06617559 Comparison of Autologous Quadriceps and Hamstring Tendon Grafts in Anterior Cruciate Ligament Reconstruction
| NCT ID | NCT06617559 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Muzaffer Agir |
| Condition | Anterior Cruciate Ligament Injuries |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2024-05-14 |
| Primary Completion | 2025-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2024-05-14 with a primary completion date of 2025-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
With the recent technological advancements, the use of the quadriceps tendon with an all-inside technique has come to the forefront, and large-scale research has focused especially on quadriceps tendon grafts. Clinical study results have reported that the outcomes are similar to those of patellar tendon grafts and either equivalent or superior to hamstring tendon grafts. The aim of this study is the prospective comparison of the clinical and radiological outcomes of patients who underwent anterior cruciate ligament (ACL) reconstruction with autologous hamstring and quadriceps tendon grafts.
Eligibility Criteria
Inclusion Criteria: * Elite athletes * Amateur athletes * Anterior cruciate ligament injury Exclusion Criteria: * Revision surgery * Another ligament injury ( medial collateral ligament, lateral collateral ligament, etc.. ) * \> Grade-2 cartilage injury * Having previously undergone surgery on the same knee * \< 18 years age
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06617559 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anterior Cruciate Ligament Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06617559 currently recruiting?
Yes, NCT06617559 is actively recruiting participants. Contact the research team at muzafferagir@gmail.com for enrollment information.
Where is the NCT06617559 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06617559 clinical trial?
NCT06617559 is sponsored by Muzaffer Agir. The trial plans to enroll 25 participants.